Literature DB >> 19132231

Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.

Samira B Jeimy1, Nola Fuller, Subia Tasneem, Kenneth Segers, Alan R Stafford, Jeffrey I Weitz, Rodney M Camire, Gerry A F Nicolaes, Catherine P M Hayward.   

Abstract

Multimerin 1 (MMRN1) is a polymeric, factor V (FV) binding protein that is stored in platelet and endothelial cell secretion granules but is undetectable in normal plasma. In human platelet alpha-granules, FV is stored complexed to MMRN1, predominantly by noncovalent binding interactions. The FV binding site for MMRN1 is located in the light chain, where it overlaps the C1 and C2 domain membrane binding sites essential for activated FV (FVa) procoagulant function. Surface plasmon resonance (SPR), circular dichroism (CD) and thrombin generation assays were used to study the binding of FV and FVa to MMRN1, and the functional consequences. FV and FVa bound MMRN1 with high affinities (K(D): 2 and 7 nM, respectively). FV dissociated more slowly from MMRN1 than FVa in SPR experiments, and CD analyses suggested greater conformational changes in mixtures of FV and MMRN1 than in mixtures of FVa and MMRN1. SPR analyses indicated that soluble phosphatidylserine (1,2-Dicaproylsn-glycero-3-phospho-L-serine) competitively inhibited both FV-MMRN1 and FVa-MMRN1 binding. Furthermore, exogenous MMRN1 delayed and reduced thrombin generation by plasma and platelets, and it reduced thrombin generation by preformed FVa. Exogenous MMRN1 also delayed FV activation, triggered by adding tissue factor to plasma, or by adding purified thrombin or factor Xa to purified FV. The high affinity binding of FV to MMRN1 may facilitate the costorage of the two proteins in platelet alpha-granules. As a consequence, MMRN1 release during platelet activation may limit platelet dependent thrombin generation in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19132231

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

Review 1.  The intersection of protein disulfide isomerase and cancer associated thrombosis.

Authors:  Jack D Stopa; Jeffrey I Zwicker
Journal:  Thromb Res       Date:  2018-04       Impact factor: 3.944

Review 2.  Thiol isomerases in thrombus formation.

Authors:  Bruce Furie; Robert Flaumenhaft
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

3.  Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.

Authors:  Jack D Stopa; Donna Neuberg; Maneka Puligandla; Bruce Furie; Robert Flaumenhaft; Jeffrey I Zwicker
Journal:  JCI Insight       Date:  2017-01-12

4.  Altered feto-placental vascularization, feto-placental malperfusion and fetal growth restriction in mice with Egfl7 loss of function.

Authors:  Lauretta A Lacko; Romulo Hurtado; Samantha Hinds; Michael G Poulos; Jason M Butler; Heidi Stuhlmann
Journal:  Development       Date:  2017-05-19       Impact factor: 6.868

Review 5.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

6.  A botanical medicine dragon's blood exhibited clinical antithrombosis efficacy similar to low molecular weight heparin.

Authors:  Jiangbin Liang; Song Mei; Xiangyu Qiao; Wei Pan; Yan Zhao; Shaohui Shi; Yaling Zhai; Haizhao Wen; Guoping Wu; Chengyu Jiang
Journal:  Sci China Life Sci       Date:  2021-01-29       Impact factor: 6.038

7.  A 2D-DIGE-based proteomic analysis reveals differences in the platelet releasate composition when comparing thrombin and collagen stimulations.

Authors:  Paula Vélez; Irene Izquierdo; Isaac Rosa; Ángel García
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

8.  Postmenopausal estrogen and progestin effects on the serum proteome.

Authors:  Sharon J Pitteri; Samir M Hanash; Aaron Aragaki; Lynn M Amon; Lin Chen; Tina Busald Buson; Sophie Paczesny; Hiroyuki Katayama; Hong Wang; Melissa M Johnson; Qing Zhang; Martin McIntosh; Pei Wang; Charles Kooperberg; Jacques E Rossouw; Rebecca D Jackson; Joann E Manson; Judith Hsia; Simin Liu; Lisa Martin; Ross L Prentice
Journal:  Genome Med       Date:  2009-12-24       Impact factor: 11.117

9.  The EMILIN/Multimerin family.

Authors:  Alfonso Colombatti; Paola Spessotto; Roberto Doliana; Maurizio Mongiat; Giorgio Maria Bressan; Gennaro Esposito
Journal:  Front Immunol       Date:  2012-01-06       Impact factor: 7.561

10.  VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets.

Authors:  Kaneo Satoh; Toshiya Hirayama; Katsuhiro Takano; Katsue Suzuki-Inoue; Tadashi Sato; Masato Ohta; Junko Nakagomi; Yukio Ozaki
Journal:  Thromb J       Date:  2013-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.